Videos
In this episode, Sophie Paczesny explains that BIOPREVENT accurately predicts individual risk of future cGVHD and NRM using biomarkers at 3 months post-HCT. A publicly available R Shiny web application supports its clinical use. Further studies are needed to explore its role in guiding preemptive therapy.
The American Society for Clinical Investigation (ASCI) honors Consuelo H. Wilkins, MD, MSCI, with the 2025 ASCI/Louis W. Sullivan, MD, Award. Dr. Wilkins is recognized for her paradigm-shifting work identifying health disparities and engaging underrepresented groups in clinical research. Dr. Wilkins is Mildred Thornton Stahlman Chair in Rural Health and Professor of Medicine in the Geriatrics Division at Vanderbilt University Medical Center as well as Associate Director for the Vanderbilt Alzheimer’s Disease Research Center and Engagement Core Director of the All of Us Research Program. She served as Founding Director of the Center for Community Health and Partnerships in the Washington University in St. Louis Institute for Public Health, Codirector of the Center for Community-Engaged Research in the Clinical and Translational Science Awards Program, and Director of Our Community, Our Health. Dr. Wilkins was elected to the National Academy of Medicine and, in 2022, the ASCI. Dr. Sherita H. Golden, Past Chair of the ASCI Physician-Scientist Engagement Committee and Hugh P. McCormick Family Professor of Endocrinology and Metabolism at the Johns Hopkins University School of Medicine, interviewed Dr. Wilkins at the AAP/ASCI/APSA Joint Meeting in Chicago in April 2025.
The American Society for Clinical Investigation (ASCI) honors Alexander G. Bick, MD, PhD, with the 2025 ASCI/Seldin~Smith Award for Pioneering Research. Dr. Bick is recognized for his application of computational genomics and experimental techniques to advancing understanding of blood cancer and cardiovascular disease. He is Director of the Division of Genetic Medicine at Vanderbilt University Medical Center and was elected to the ASCI in 2025. Dr. Bick received his MD and PhD in genetics from Harvard and completed a residency at Massachusetts General Hospital (MGH) and fellowship at the Broad Institute. Rajan Jain, MD, ASCI Councilor and William Wikoff Smith Associate Professor in Cardiovascular Research at the University of Pennsylvania Perelman School of Medicine, interviewed Dr. Bick at the AAP/ASCI/APSA Joint Meeting in Chicago in April 2025.
The American Society for Clinical Investigation (ASCI) honors W. Kimryn Rathmell, MD, PhD, with the 2025 ASCI/Stanley J. Korsmeyer Award. Dr. Rathmell is recognized for her contributions to understanding the biologies driving cancer arising in the kidney and her advocacy for the careers of physician-scientists. Dr. Rathmell recently became CEO of The Ohio State University (OSU) Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. She is former director of the National Cancer Institute (NCI), before which she was Hugh Jackson Morgan Professor in the Department of Medicine at Vanderbilt University Medical Center and served on the faculty of the University of North Carolina at Chapel Hill. Dr. Rathmell was elected to the National Academy of Medicine and the American Academy of Arts and Sciences, is a fellow of the American Association for the Advancement of Science, and is a past president of the ASCI (2019–2020). Dr. Benjamin D. Humphreys, MD, PhD, ASCI Past President (2023–2024), Joseph Friedman Professor of Renal Diseases in Medicine, and Chief of the Division of Nephrology at Washington University in St. Louis, interviewed Dr. Rathmell at the AAP/ASCI/APSA Joint Meeting in Chicago in April 2025.
The American Society for Clinical Investigation (ASCI) honors Ann Chahroudi, MD, PhD, with the 2025 ASCI/Marian W. Ropes, MD, Award. Dr. Chahroudi is recognized for her contributions to the development of novel pediatric models of postnatal HIV and Zika virus infections. She is Professor and Vice Chair for Basic Science and Career Development in the Department of Pediatrics at Emory University School of Medicine. Dr. Chahroudi is also Founding Director of the Pediatric Residency Investigative Scholars at Emory program, Codirector of the Emory Center for AIDS Research, and co–principal investigator for the Martin Delaney Pediatric Adolescent Virus Elimination (PAVE) Collaboratory. Dr. Chahroudi was elected to the ASCI in 2022. Dr. Julie Saba, MD, PhD, an ASCI Physician-Scientist Engagement Committee member and The John & Edna Beck Chair in Pediatric Cancer Research at the University of California, San Francisco, interviewed Dr. Chahroudi in July 2025.
Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)